Pathogenic and protective roles of cytokines in pemphigus: a systematic review

S Tavakolpour, HR Mahmoudi, A Mirzazadeh, K Balighi… - Cytokine, 2020 - Elsevier
Pemphigus is a rare and life-threatening group of blistering autoimmune diseases that
affects the skin and mucous membranes. There are two major subtypes of pemphigus …

Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid

EH Kowalski, D Kneibner, K Kridin, KT Amber - Autoimmunity reviews, 2019 - Elsevier
Bullous pemphigoid and pemphigus constitute two major autoimmune blistering diseases
(AIBD) with complicated disease pathomechanisms involving a multitude of cytokines and …

[HTML][HTML] Analysis of serum cytokine profile in pemphigus

SH Lee, WJ Hong, SC Kim - Annals of dermatology, 2017 - ncbi.nlm.nih.gov
Background Pemphigus is a group of autoimmune blistering diseases affecting skin and
mucous membranes. While pemphigus is an autoantibody mediated disease, the role of T …

The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets

R Maglie, F Solimani, D Didona, C Pipitò… - Frontiers in …, 2023 - frontiersin.org
Bullous pemphigoid (BP) is the most common autoimmune bullous disease, characterized
by severe pruritus and skin blistering. The loss of tolerance against Collagen XVII, also …

Immune cells in pemphigus vulgaris and bullous Pemphigoid: From pathogenic roles to targeting therapies

Q Yuan, W Yang, X Zhang - International Immunopharmacology, 2023 - Elsevier
Pemphigus vulgaris (PV) and bullous pemphigoid (BP) are two major subtypes of
autoimmune bullous diseases (AIBD), characterized by blisters and erosions of skin and/or …

The effect of conventional immunosuppressive therapy on cytokine serum levels in pemphigus vulgaris patients

H Mortazavi, N Esmaili, S Khezri, A Khamesipour… - 2014 - sid.ir
Pemphigus vulgaris is an autoimmune disease, in which the role of Th17 cytokines needs to
be further explored. This study was performed to assess serum levels of three interleukins …

Interleukin 4 inhibition as a potential therapeutic in pemphigus

S Tavakolpour, V Tavakolpour - Cytokine, 2016 - Elsevier
Pemphigus is an autoimmune bullous skin disease that results from desmosomal protein
desmoglein 3 and 1 loss in pemphigus vulgaris and foliaceus, respectively. It can be …

Cytokine networks in Pemphigus vulgaris: An integrated viewpoint

CN Giordano, AA Sinha - Autoimmunity, 2012 - Taylor & Francis
Pemphigus vulgaris (PV) is an autoimmune bullous skin disease where tolerance to the
desmosomal protein desmoglein 3 (Dsg3), and perhaps additional epidermal targets, is lost …

[HTML][HTML] The relevance of complement in pemphigoid diseases: a critical appraisal

C Papara, CM Karsten, H Ujiie, E Schmidt… - Frontiers in …, 2022 - frontiersin.org
Pemphigoid diseases are autoimmune chronic inflammatory skin diseases, which are
characterized by blistering of the skin and/or mucous membranes, and circulating and tissue …

[HTML][HTML] Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid

M Rosi-Schumacher, J Baker, J Waris… - Frontiers in …, 2023 - frontiersin.org
Autoimmune blistering diseases such as bullous pemphigoid (BP) and pemphigus vulgaris
(PV) are complex, multifactorial, and polygenic diseases, whose exact pathogenesis is …